This aligns with the literature indicating that obesity alters VD metabolism, with elevated PTH and disrupted regulation of 1,25(OH)2D due to changes in VD-metabolizing enzymes [88]. The gene discussed is PTH; the disease is obesity due to melanocortin 4 receptor deficiency.